Beacon-based (bbFISH®) technology for rapid pathogens identification in blood cultures

BMC Microbiology

Volumn 14, Issue 1, 2014, Pages

  Sakarikou, Christina ^b   Parisato, Martina ^c   Cascio, Giuliana Lo ^c   Fontana, Carla ^a,b  

^a UNIVERSITY OF ROME TOR VERGATA   (Italy)

^b TOR VERGATA UNIVERSITY HOSPITAL   (Italy)

^c UNIVERSITY HOSPITAL OF VERONA   (Italy)

Author keywords

Beacon based FISH; hemoFISH; Rapid test; Sepsis

Indexed keywords

ARTICLE; BACTERIUM IDENTIFICATION; BEACON BASED FLUORESCENT IN SITU HYBRIDIZATION; BLOOD CULTURE; FLUORESCENCE IN SITU HYBRIDIZATION; HUMAN; MAJOR CLINICAL STUDY; NONHUMAN; PATHOGENESIS; SENSITIVITY AND SPECIFICITY; SEPSIS;

BACTERIA (MICROORGANISMS); NEGIBACTERIA; NUCLEOPOLYHEDROVIRUS; POSIBACTERIA;

BLOOD; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; MICROBIOLOGICAL TECHNIQUES; MOLECULAR DIAGNOSTIC TECHNIQUES; SENSITIVITY AND SPECIFICITY; SEPSIS; TIME FACTORS;

EID: 84899586721     PISSN: None     EISSN: 14712180     Source Type: Journal    
DOI: 10.1186/1471-2180-14-99     Document Type: Article

References (30)

1. The immunopathogenesis of sepsis. Cohen J, Nat 2002 420 885 891 10.1038/nature01326 (Pubitemid 36019643)
2. The pathophysiology and treatment of sepsis. Hotchkiss RS, Karl I, New Engl J Med 2003 348 138 150 10.1056/NEJMra021333 12519925 (Pubitemid 36056721)
3. Sepsis: definition, epidemiology and diagnosis. Lever A, MacKenzie I, BMJ 2007 335 879 883 10.1136/bmj.39346.495880.AE 17962288 (Pubitemid 350069465)
4. The international sepsis forum consensus conference on definitions of infection in the intensive care unit. Calandra T, Cohen J, Crit Care Med 2005 33 1538 1548 10.1097/01.CCM.0000168253.91200.83 16003060 (Pubitemid 40980610)
5. Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock: 2008. Dellinger R, Levy M, Carlet J, Bion J, Parker M, Jaeschke R, Reinhart K, Angus DC, Brun-Buisson C, Beale R, Calandra T, Dhainaut JF, Gerlach H, Harvey M, Marini JJ, Marshall J, Ranieri M, Ramsay G, Sevransky J, Thompson BT, Townsend S, Vender JS, Zimmerman JL, Vincent JL, Crit Care Med 2008 34 17 60
6. Investigation of blood cultures (for organisms other than Mycobacterium species). Health Protection Agency, National Standard Method.London, Standards Unit 2012 B37 6.1 Available online at http://www.hpa.org.uk/webc/HPAwebFile/ HPAweb-C/1317132857861
7. Inadequate antimicrobial treatment of infections: a risk factor of hospital mortality among critically ill patients. Kollef M, Sherman G, Ward S, Fraser V, Chest 1999 115 462 474 10.1378/chest.115.2.462 10027448 (Pubitemid 29083057)
8. Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock. Kumar A, Roberts D, Wood KE, Light B, Parrillo JE, Sharma S, Suppes R, Feinstein D, Zanotti S, Taiberg L, Gurka D, Kumar A, Cheang M, Crit Care Med 2006 34 1589 1596 10.1097/01.CCM.0000217961.75225.E9 16625125 (Pubitemid 43810035)
9. Diagnostic techniques in bloodstream infections: where are we going? Stefani S, Int Antimicrob Agents 2009 34 9 12
10. Fluorescence in situ hybridization (FISH) for direct visualization of microorganisms. Moter A, Göbel UB, J Microb Meth 2000 41 85 112 10.1016/S0167-7012(00)00152-4 (Pubitemid 30411942)
11. Fluorescence in situ hybridization to improve the diagnosis of endocarditis: a pilot study. Mallmann C, Siemoneit S, Schmiedel D, Petrich A, Gescher DM, Halle E, Musci M, Hetzer R, Göbel UB, Moter A, Clin Microbiol Infect 2010 16 767 773 10.1111/j.1469-0691.2009.02936.x 19694763
12. Rapid diagnosis of bacterial meningitis by real-time PCR and fluorescence in situ hybridization. Poppert S, Essig A, Stoehr B, Steingruber A, Wirths B, Juretschko S, Reischl U, Wellinghausen N, J Clin Microbiol 2005 43 3390 3397 10.1128/JCM.43.7.3390-3397.2005 16000464 (Pubitemid 40981352)
13. Rapid differentiation of Francisella species and subspecies by fluorescent in situ hybridization targeting the 23S rRNA. Splettstoesser WD, Seibold E, Zeman E, Trebesius K, Podbielski A, BMC Microbiol 2010 10 72 10.1186/1471-2180-10-72 20205957
14. Rapid detection of Brucella spp. in blood cultures by fluorescence in situ hybridization. Wellinghausen N, Nöckler K, Sigger A, Bartel M, Essig A, Poppert S, J Clin Microbiol 2006 44 1828 1830 10.1128/JCM.44.5.1828-1830.2006 16672413 (Pubitemid 43726275)
15. Superiority of molecular techniques for identification of Gram-negative, oxidase-positive rods, including morphologically non typical Pseudomonas aeruginosa, from patients with cystic fibrosis. Wellinghausen N, Köthe J, Wirths B, Sigge A, Poppert S, J Clin Microbiol 2005 43 4070 4075 10.1128/JCM.43.8.4070-4075.2005 16081953 (Pubitemid 41129702)
16. Rapid diagnosis of intrapartum group B streptococcal carriage by fluorescent in situ hybridization. Goddard KA, Townsend R, Ridgway E, J Clin Pathol 2007 60 842 843 17596553 (Pubitemid 47056924)
17. Fluorescent oligonucleotide probing of whole cells for determinative, phylogenetic, and environmental studies in microbiology. Amman RI, Krumholz L, Stahl DA, J Bacteriol 1990 172 762 770 1688842 (Pubitemid 20070387)
18. Molecular Beacons: Probes that fluoresce upon hybridization. Tyagi S, Kramer FR, Nat Biotechnol 1996 14 303 308 10.1038/nbt0396-303 9630890 (Pubitemid 3035126)
19. Effects of rapid detection of bloodstream infections on length of hospitalization and hospital charges. Beckmann SE, Diekema DJ, Chapin KC, Doern GV, J Clin Microbiol 2003 41 3119 3125 10.1128/JCM.41.7.3119-3125.2003 12843051 (Pubitemid 36842309)
20. Decreased mortality associated with prompt Gram staining of blood cultures. Barenfanger J, Graham DR, Kolluri L, Sangwan G, Lawhorn J, Drake CA, Verhulst SJ, Peterson R, Moja LB, Ertmoed MM, Moja AB, Shevlin DW, Vautrain R, Callahan CD, Am J Clin Pathol 2008 130 870 6 10.1309/AJCPVMDQU2ZJDPBL 19019762
21. Laboratory turnaround time. Hawkins RC, Clin Biochem Rev 2007 28 179 194 18392122
22. Physician satisfaction and emergency department laboratory test turnaround time. Steindel SJ, Howanitz PJ, Arch Pathol Lab Med 2001 125 863 71 11419969
23. Evaluation of stat and routine turnaround times as a component of laboratory quality. Hilborne LH, Oye RK, McArdle JE, Repinski JA, Rodgerson DO, Am J Clin Pathol 1989 91 331 335 2923096 (Pubitemid 19074548)
24. The clinical diagnostic accuracy of rapid detection of healthcare-associated bloodstream infection in intensive care using multi patho genereal-time PCR technology. Dark P, Dunn G, Chadwick P, Young D, Bentley A, Carlson G, Warhurst G, BMJ Open 2011 1 000181 22021785
25. Comparative analysis of PCR-electrospray ionization/mass spectrometry (MS) and MALDI-TOF/MS for the identification of bacteria and yeast from positive blood-culture bottles. Kaleta EJ, Clark AE, Cherkaoui A, Wysocki VH, Ingram EL, Schrenzel J, Wolk DM, Clin Chem 2011 57 1057 67 10.1373/clinchem.2011.161968 21576270
26. Rapid identification of bacteria from positive blood culture bottles by use of matrix-assisted laser desorption-ionization time of flightmass spectrometry fingerprinting. Christner M, Rohde H, Wolters M, Sobottka I, Wegscheider K, Aepfelbacher M, J Clin Microbiol 2010 48 1584 91 10.1128/JCM.01831-09 20237093
27. Laboratory turnaround time. Valenstein P, Am J Clin Pathol 1996 105 676 688 8659441 (Pubitemid 126500576)
28. Sensitivity, specificity, and reproducibility of four measures of laboratory turnaround time. Valenstein PN, Emancipator K, Am J Clin Pathol 1989 92 613 618 2816813
29. The regulation of promoter selectivity in eubacteria. Travers A, DNA-Protein Interactions New York: Chapman and Hall 1993 109 129 http://link.springer.com/chapter/10.1007%2F978-94-011-1480-6-5
30. A novel culturing system for fluid samples. Fontana C, Favaro M, Minelli S, Bossa MC, Altieri A, Favalli C, Med Sci Monit 2009 15 R55 BR60 19179962